MDT - Medtronic plc

NYSE - NYSE Delayed Price. Currency in USD
97.85
+0.37 (+0.38%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close97.48
Open97.59
Bid97.00 x 800
Ask100.00 x 21500
Day's Range96.96 - 98.00
52 Week Range76.41 - 98.00
Volume7,973,693
Avg. Volume4,598,585
Market Cap132.147B
Beta0.70
PE Ratio (TTM)42.19
EPS (TTM)2.32
Earnings DateNov 20, 2018
Forward Dividend & Yield2.00 (2.06%)
Ex-Dividend Date2018-09-27
1y Target Est102.60
Trade prices are not sourced from all markets
  • Late-Breaking Clinical Study Results Demonstrate Exceptional Safety and Efficacy Outcomes for Resolute Onyx(TM) DES
    GlobeNewswire20 hours ago

    Late-Breaking Clinical Study Results Demonstrate Exceptional Safety and Efficacy Outcomes for Resolute Onyx(TM) DES

    September 22, 2018 - Investigators today unveiled new clinical data from the physician-initiated BIONYX study, representing the first all-comers analysis in nearly 2,500 patients comparing the safety and efficacy of the durable polymer Resolute Onyx(TM) drug-eluting stent (DP-DES) from Medtronic plc (MDT) to the Orsiro biodegradable polymer stent (BP-DES). At one year, the study showed patients with coronary artery disease who were treated with Orsiro BP-DES received no clinical advantage compared to patients treated with the Resolute Onyx DP-DES, and Orsiro BP-DES demonstrated a higher rate of stent thrombosis.1 Published simultaneously in The Lancet, the results were presented today during a Late-Breaking Clinical Trial session at the 30th Transcatheter Cardiovascular Therapeutics conference (TCT), the annual scientific symposium of the Cardiovascular Research Foundation.

  • 4 Days Left Until Medtronic plc (NYSE:MDT) Trades Ex-Dividend,
    Simply Wall St.yesterday

    4 Days Left Until Medtronic plc (NYSE:MDT) Trades Ex-Dividend,

    Investors who want to cash in on Medtronic plc’s (NYSE:MDT) upcoming dividend of US$0.50 per share have only 4 days left to buy the shares before its ex-dividend date, 27Read More...

  • CNBC2 days ago

    Cramer's lightning round: Don't get speculative with oil and gas stocks

    It's that time again! "Mad Money" host Jim Cramer rang the lightning round bell, which means he gave his take on callers' favorite stocks at rapid speed. Notice how FedEx has come right back even though it was supposed to be such a disappointing quarter. ActionAlerts, my charitable trust, has others, but they may be too so-called go-go for you.

  • What Happened in the Stock Market Today
    Motley Fool2 days ago

    What Happened in the Stock Market Today

    On a mixed day for the major benchmarks, Medtronic announced plans to buy Mazor Robotics, and Micron Technology beat expectations for its latest quarter.

  • Why Medtronic Is Buying This Growing Robotics Company
    Motley Fool2 days ago

    Why Medtronic Is Buying This Growing Robotics Company

    Medtronic's collaboration with Mazor Robotics has resulted in an outright acquisition.

  • Is Medtronic Paying Too Much for Mazor Robotics?
    Motley Fool2 days ago

    Is Medtronic Paying Too Much for Mazor Robotics?

    This medical-device titan is paying up to swallow the robotic-surgery upstart whole. Does the deal make sense?

  • Mazor Robotics Stock Soars on Medtronic Deal
    InvestorPlace2 days ago

    Mazor Robotics Stock Soars on Medtronic Deal

    The deal will have Medtronic acquiring Mazor Robotics (OTCMKTS:MZRTF) for $1.64 billion. It will be doing this by purchasing all outstanding shares of Mazor Robotics stock for $58.50 per American Depository Share, or $29.25 per ordinary share. Medtronic says that it will be using cash to fund its acquisition of Mazor Robotics stock.

  • GlobeNewswire2 days ago

    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Mazor Robotics, Inc. to Medtronic plc is Fair to Shareholders

    NEW YORK, Sept. 21, 2018-- The following statement is being issued by Levi & Korsinsky, LLP:. To: All Persons or Entities who purchased Mazor Robotics, Inc. stock prior to September 20, 2018. You are hereby ...

  • Stocks - Micron Sinks in Pre-market; Wells Fargo, Tesla Fall; Apple, Walmart Gain
    Investing.com2 days ago

    Stocks - Micron Sinks in Pre-market; Wells Fargo, Tesla Fall; Apple, Walmart Gain

    Investing.com - Stocks in focus in pre-market trade Friday:

  • Here's Why Mazor Robotics Is Soaring Today
    Motley Fool2 days ago

    Here's Why Mazor Robotics Is Soaring Today

    Shares jump after the company accepts a buyout offer. Here's what investors need to know.

  • Medtronic to Buy Mazor Robotics for Robotic Spine Surgery
    Zacks2 days ago

    Medtronic to Buy Mazor Robotics for Robotic Spine Surgery

    The consolidation will combine Medtronic's (MDT) spine implants, navigation and intra-operative imaging technology with Mazor Robotics' robotic-assisted surgery (RAS) systems.

  • The Wall Street Journal2 days ago

    [$$] Stocks to Watch: Micron, Alphabet, Medtronic, Adobe Systems, Wells Fargo, United Natural Foods, General Electric, Eventbrite, MDC Partners

    Here are some of the companies with shares expected to trade actively in Friday’s session. Check back closer to the market open for an updated list. Micron Technology Inc.—Down 2.7%: The memory chip maker issued a disappointing forecast with its fiscal fourth-quarter report, expecting revenue for the quarter ending in November to grow by its slowest rate in two years.

  • Benzinga2 days ago

    The Daily Biotech Pulse: Exelixis Liver Cancer Drug On Track For European Approval, Medtronic Goes Shopping, Opiant Snags BARDA Funding

    The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 20.) Abbott Laboratories (NYSE: ABT ) Acceleron ...

  • Abbott Laboratories’ 379th Consecutive Quarterly Dividend
    Market Realist2 days ago

    Abbott Laboratories’ 379th Consecutive Quarterly Dividend

    On September 13, Abbott Laboratories (ABT) announced its 379th consecutive quarterly dividend, which is payable on November 15. The dividend of $0.28 per share will be paid to shareholders of record as of the close of business on October 15. The company’s annual dividend in 2017 was $1.06, while its indicated annual dividend for 2018 is $1.12 per share. Last year, it paid a quarterly dividend of $0.265 to its shareholders, so its new quarterly dividend represents an increase of ~5.7%.

  • Reuters2 days ago

    Deals of the day-Mergers and acquisitions

    Sept 21 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Friday: ** Adobe Systems Inc has agreed to buy Marketo Inc for $4.75 billion from private equity ...

  • Reuters2 days ago

    Medtronic to acquire Mazor in $1.64 billion deal

    Medtronic agreed to pay $58.50 per American Depository Share or $29.25 (104.80 shekels) per ordinary share in cash and the boards of both companies unanimously approved the deal. Medtronic, which held a stake of about 11 percent prior to the deal, said the deal was expected to be modestly dilutive to its fiscal 2019 adjusted earnings per share.

  • Reuters2 days ago

    Medtronic to acquire Mazor in $1.64 billion deal

    Medical equipment company Medtronic Plc will acquire Israel-based Mazor Robotics for about $1.64 billion in an all-cash deal, or $1.34 billion net of Medtronic's existing stake in Mazor, the companies said on Thursday. Medtronic agreed to pay $58.50 per American Depository Share or $29.25 (104.80 shekels) per ordinary share in cash and the boards of both companies unanimously approved the deal. Medtronic, which held a stake of about 11 percent prior to the deal, said the deal was expected to be modestly dilutive to its fiscal 2019 adjusted earnings per share.

  • The Wall Street Journal2 days ago

    Medtronic to Buy Mazor Robotics for $1.6 Billion

    Under the agreement, Dublin-based Medtronic will acquire all outstanding ordinary shares of Israel-based Mazor Robotics for $58.50 per American Depository Share, or $29.25 per ordinary share, in cash. The deal is expected to close during Medtronic’s third fiscal quarter, ending Jan. 25, the companies said Thursday. ADRs of Mazor closed Thursday at $52.75 and its ordinary shares closed at $26.25.

  • PR Newswire3 days ago

    Medtronic To Acquire Mazor Robotics

    DUBLIN and CAESAREA, Israel, Sept. 20, 2018 /PRNewswire/ -- Medtronic plc (MDT), a global leader in medical technology, and Mazor Robotics (NASDAQ: MZOR, TASE: MZOR.TA), a pioneer in the field of robotic guidance systems, today announced the companies have entered into a definitive merger agreement under which Medtronic will acquire all outstanding ordinary shares of Mazor for $58.50 per American Depository Share, or $29.25 (104.80 ILS) per ordinary share, in cash, for a total of approximately $1.64 billion, or $1.34 billion net of Medtronic's existing stake in Mazor and cash acquired. Medtronic's acquisition of Mazor strengthens Medtronic's position as a global leader in enabling technologies for spine surgery, and drives Mazor Robotics' vision to bring its core technology to the forefront of the global market.

  • Medtronic Agrees to Buy Mazor Robotics in $1.6 Billion Deal
    Bloomberg3 days ago

    Medtronic Agrees to Buy Mazor Robotics in $1.6 Billion Deal

    Medtronic Plc, agreed to buy Mazor Robotics Ltd., a maker of robotic guidance systems, in a $1.64 billion cash deal to strengthen its position in technology for spine surgery. Medtronic agreed to pay $58.50 per American depositary share for the stock in Mazor that it doesn’t already own, the companies said in a joint statement Thursday. Medtronic previously held an 11 percent stake in the Israel-based company, according to Bloomberg data.

  • MarketWatch3 days ago

    Medtronic to buy Mazor Robotics for $1.64 billion

    Medtronic PLC said late Thursday that it plans to buy the Israel-based Mazor Robotics Ltd. for $1.64 billion in cash. Mazor stock is up 7.5% and Medtronic fell less than 0.1% after hours. The S&P 500 index closed up 0.8%. Medtronic, a medical technology maker, said it would pay $58.50 for each American Depository Share of Mazor, which makes robotic guidance systems that are applied to medical tech. "The Mazor team and product portfolio's full integration into Medtronic will maximize our impact globally through Medtronic's channels, advance our systems' leadership position in the marketplace, and drive the realization of our vision to heal through innovation," said Mazor CEO Ori Hadomi. The acquisition is expected to close during Medtronic's third fiscal quarter, which ends Jan. 25, 2019.

  • Medtronic to Acquire Mazor Robotics
    GlobeNewswire3 days ago

    Medtronic to Acquire Mazor Robotics

    September 20, 2018 - Medtronic plc (MDT), a global leader in medical technology, and Mazor Robotics (NASDAQ:MZOR, TASE:MZOR.TZ), a pioneer in the field of robotic guidance systems, today announced the companies have entered into a definitive merger agreement under which Medtronic will acquire all outstanding ordinary shares of Mazor for $58.50 per American Depository Share, or $29.25 (104.80 ILS) per ordinary share, in cash, for a total of approximately $1.64 billion, or $1.34 billion net of Medtronic`s existing stake in Mazor and cash acquired. The boards of directors of both companies have unanimously approved the transaction. Medtronic`s acquisition of Mazor strengthens Medtronic`s position as a global leader in enabling technologies for spine surgery, and drives Mazor Robotics` vision to bring its core technology to the forefront of the global market.

  • Benzinga3 days ago

    Medtronic Is At All-Time Highs, But The Top Looks Like It's In

    The following stock has been highlighted by VantagePoint Software , an artificial intelligence platform that provides market forecasts 1-3 days in advance. For a free demo click here.  Shares of Medtronic ...

  • ABT Returns Almost Double the S&P 500’s Year-to-Date Gain
    Market Realist3 days ago

    ABT Returns Almost Double the S&P 500’s Year-to-Date Gain

    As of September 19, Abbott Laboratories (ABT) has registered a rise of ~17% YTD (year-to-date). In the same period, the S&P 500 has risen ~8%. Abbott Laboratories has clearly surpassed the market’s returns so far in 2018.

  • 8 Long-Term Investments to Give Your Grandchildren
    InvestorPlace3 days ago

    8 Long-Term Investments to Give Your Grandchildren

    Sensible investors years ago could have chosen market leaders like Polaroid, General Motors (NYSE:GM), Sears (NASDAQ:SHLD), and myriad other ‘safe’, seemingly dominant stocks that would go on to stumble badly — or even go bankrupt. It’s far from guaranteed, however, that even torrid growth will produce much in the way of long-term returns relative to the stocks’ current prices.